| Tamoxifen Treatment in Patients With Motor Neuron Disease (NCT02166944) | Taipei Medical University Shuang Ho Hospital | 2014-04-01 |
| Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis (NCT02039401) | Helixmith Co., Ltd. | 2014-03-11 |
| Study of Gene Polymorphisms Involved in the Metabolism and Action of Vitamin D in Amyotrophic Lateral Sclerosis (NCT02893605) | Centre Hospitalier Universitaire de Nīmes | 2014-03-01 |
| Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS (NCT01759784) | Royan Institute | 2014-03-01 |
| Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS (NCT02645461) | University of Roma La Sapienza | 2014-01-01 |
| Innovative Ultrasound Technology in Neuromuscular Disease (NCT02104921) | Beth Israel Deaconess Medical Center | 2013-12-01 |
| Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis (NCT02058732) | University of Michigan | 2013-11-01 |
| Study of Electrical Impedance Myography (EIM) in ALS (NCT02011204) | Skulpt, Inc. | 2013-11-01 |
| PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis (NCT01508962) | University of Miami | 2013-11-01 |
| Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis (NCT01959373) | Assistance Publique Hopitaux De Marseille | 2013-10-01 |
| Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS) (NCT02000713) | University of Michigan | 2013-10-01 |
| Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation (NCT01925196) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-09-30 |
| A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01935518) | Peking University Third Hospital | 2013-09-01 |
| Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS) (NCT02507713) | Universidad Católica San Antonio de Murcia | 2013-09-01 |
| Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders (NCT05116943) | Mayo Clinic | 2013-08-19 |
| Gilenya in Amyotrophic Lateral Sclerosis (ALS) (NCT01786174) | Massachusetts General Hospital | 2013-08-01 |
| Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS (NCT01771640) | Royan Institute | 2013-08-01 |
| GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) (NCT01854294) | Genervon Biopharmaceuticals, LLC | 2013-08-01 |
| A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis (NCT01906658) | Mallinckrodt | 2013-07-01 |
| Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study (NCT01897818) | Centre Hospitalier Universitaire de Nice | 2013-07-01 |
| Longitudinal Study of Outcomes Measures in ALS Trials (NCT01911130) | Massachusetts General Hospital | 2013-07-01 |
| From Movement Preparation to Gait Execution in ALS (NCT01874808) | Institut National de la Santé Et de la Recherche Médicale, France | 2013-06-21 |
| Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (NCT01879241) | University of Ulm | 2013-06-01 |
| Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (NCT01730716) | Neuralstem Inc. | 2013-05-01 |
| Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS (NCT01759797) | Royan Institute | 2013-01-01 |
| Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis (NCT01753076) | GlaxoSmithKline | 2012-12-20 |
| Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (NCT01758510) | Hanyang University Seoul Hospital | 2012-12-01 |
| Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01777646) | Brainstorm-Cell Therapeutics | 2012-12-01 |
| Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study (NCT01639391) | Institut Pasteur | 2012-11-29 |
| The Effect of GCSF in the Treatment of ALS Patients (NCT01825551) | Tehran University of Medical Sciences | 2012-11-01 |
| Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) (NCT01709149) | Cytokinetics | 2012-10-01 |
| In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS) (NCT02582385) | Brugmann University Hospital | 2012-10-01 |
| Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls (NCT01160263) | Assistance Publique - Hôpitaux de Paris | 2012-10-01 |
| EEG and TMS-based Biomarkers of ALS, MS and FTD (NCT04918251) | University of Dublin, Trinity College | 2012-09-01 |
| Influence of the Vitamin D Blood Levels on the Amyotrophic Lateral Sclerosis Phenotype (NCT01823380) | University Hospital, Montpellier | 2012-09-01 |
| Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation (NCT01583088) | Assistance Publique - Hôpitaux de Paris | 2012-09-01 |
| Multidisciplinary Follow-up of Patients With Amyotrophic Lateral Sclerosis (NCT03536962) | Ruxandra Iancu Ferfoglia | 2012-06-01 |
| Phase 3 Extension Study of Dexpramipexole in ALS (NCT01622088) | Knopp Biosciences | 2012-06-01 |
| A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis (NCT01609283) | Mayo Clinic | 2012-05-01 |
| Developing a Discrimination Model to Diagnose ALS (NCT01995903) | University of Michigan | 2012-04-01 |
| Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients (NCT01641965) | Hospital Universitari de Bellvitge | 2012-04-01 |
| The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis (NCT01494480) | General Hospital of Chinese Armed Police Forces | 2012-03-01 |
| Dexpramipexole and Cimetidine Drug Drug Interaction (DDI) (NCT01536249) | Knopp Biosciences | 2012-03-01 |
| Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) (NCT01565395) | Beth Israel Deaconess Medical Center | 2012-03-01 |
| Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea (NCT01551940) | Hospices Civils de Lyon | 2012-02-01 |
| Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation (NCT01378026) | China Medical University Hospital | 2012-01-01 |
| Aerobic Exercise Training in Amyotrophic Lateral Sclerosis (NCT01650818) | Fondazione Salvatore Maugeri | 2012-01-01 |
| Monitoring of Non-invasive Ventilation During Sleep in ALS (NCT01889043) | Universitaire Ziekenhuizen KU Leuven | 2012-01-01 |
| Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate) (NCT01511029) | Knopp Biosciences | 2012-01-01 |
| Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) (NCT01640067) | Azienda Ospedaliera Santa Maria, Terni, Italy | 2011-12-01 |
| A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers (NCT01495390) | Massachusetts General Hospital | 2011-11-01 |
| Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01486849) | Cytokinetics | 2011-11-01 |
| Dexpramipexole SAD/MAD Study (NCT01449578) | Knopp Biosciences | 2011-11-01 |
| Olfactory Deficits in Neurologic Disease (NCT05019014) | Massachusetts General Hospital | 2011-08-10 |
| Dexpramipexole Japanese PK Study (NCT01424163) | Knopp Biosciences | 2011-08-01 |
| Dexpramipexole Renal PK Study (NCT01424176) | Knopp Biosciences | 2011-07-01 |
| Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. (NCT01051882) | Brainstorm-Cell Therapeutics | 2011-06-01 |
| A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01378676) | Cytokinetics | 2011-06-01 |
| Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01504009) | University of Southern Denmark | 2011-05-01 |
| Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) (NCT01257581) | Nazem Atassi | 2011-03-01 |
| Nightime NIV Initiation in Amyotrophic Lateral Sclerosis in an Outpatient Setting (NCT02759003) | Fondazione Salvatore Maugeri | 2011-03-01 |
| Phase 3 Study of Dexpramipexole in ALS (NCT01281189) | Knopp Biosciences | 2011-03-01 |
| Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (NCT01363401) | Corestemchemon, Inc. | 2011-02-01 |
| Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes (NCT02880033) | University Hospital, Lille | 2011-02-01 |
| A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01281631) | Neuraltus Pharmaceuticals, Inc. | 2011-02-01 |
| Transplantation of Autologous Peripheral Blood Mononuclear Cells for Amyotrophic Lateral Sclerosis (NCT03085706) | The First Affiliated Hospital of Dalian Medical University | 2010-10-01 |
| Safety Extension Study of TRO19622 in ALS (NCT01285583) | Hoffmann-La Roche | 2010-10-01 |
| Safety Study of High Doses of Zinc in ALS Patients (NCT01259050) | Phoenix Neurological Associates, LTD | 2010-10-01 |
| The National Amyotrophic Lateral Sclerosis Registry (NCT01772602) | Centers for Disease Control and Prevention | 2010-10-01 |
| Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) (NCT01254539) | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 2010-10-01 |
| Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life (NCT01160367) | Johns Hopkins University | 2010-08-26 |
| Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS) (NCT01091142) | Neuraltus Pharmaceuticals, Inc. | 2010-07-01 |
| Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) (NCT01142856) | Mayo Clinic | 2010-06-01 |
| Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis (NCT01082653) | TCA Cellular Therapy | 2010-03-01 |
| A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01089010) | Cytokinetics | 2010-03-01 |
| A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral Sclerosis (NCT01119001) | University of Michigan | 2010-02-01 |
| An In-home Study of Brain Computer Interfaces (NCT01123200) | University of Michigan | 2010-01-01 |
| Biological Treatment of Amyotrophic Lateral Sclerosis (NCT02193893) | Pomeranian Medical University Szczecin | 2010-01-01 |
| A P300 Brain Computer Interface to Operate Power Wheelchair Tilt (NCT01123148) | University of Michigan | 2010-01-01 |
| Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases (NCT01954875) | Wake Forest University Health Sciences | 2009-12-02 |
| Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate (NCT01955369) | Klinikum Ludwigshafen | 2009-10-01 |
| High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis (NCT00983983) | Massachusetts General Hospital | 2009-10-01 |
| Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS) (NCT00982150) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-09-01 |
| Escitalopram (Lexapro) for Depression MS or ALS (NCT00965497) | University of South Carolina | 2009-07-01 |
| Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211) (NCT00931944) | Knopp Biosciences | 2009-07-01 |
| Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis (NCT00925847) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis (NCT01384162) | Newron Sweden AB | 2009-06-01 |
| Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders (NCT00839033) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis (NCT00875446) | GlaxoSmithKline | 2009-05-13 |
| BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia (NCT00912041) | Leigh R. Hochberg, MD, PhD. | 2009-05-01 |
| Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS (NCT00868166) | Hoffmann-La Roche | 2009-04-30 |
| Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00879593) | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | 2009-04-01 |
| Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis (NCT01530438) | University Hospital, Caen | 2009-04-01 |
| Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS) (NCT00886977) | Yoshino Neurology Clinic | 2009-04-01 |
| Neuromuscular Transmission in Amyotrophic Lateral Sclerosis (NCT00847847) | Assistance Publique - Hôpitaux de Paris | 2009-03-01 |
| Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS) (NCT00956501) | Wake Forest University Health Sciences | 2009-02-01 |
| Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS) (NCT00838617) | Vanderbilt University | 2009-02-01 |
| Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders (NCT01459302) | University of Massachusetts, Worcester | 2009-01-01 |
| Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) (NCT00818389) | Massachusetts General Hospital | 2009-01-01 |
| Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral Sclerosis (NCT00958048) | National Taiwan University Hospital | 2009-01-01 |